U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H19N3O3S
Molecular Weight 345.416
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OMEPRAZOLE

SMILES

COC1=CC2=C(NC(=N2)[S+]([O-])CC3=C(C)C(OC)=C(C)C=N3)C=C1

InChI

InChIKey=SUBDBMMJDZJVOS-UHFFFAOYSA-N
InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)

HIDE SMILES / InChI
Molecular Formula C17H19N3O3S
Molecular Weight 345.416
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:41:37 UTC 2023
Edited
by admin
on Fri Dec 15 17:41:37 UTC 2023
Record UNII
KG60484QX9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OMEPRAZOLE
EP   GREEN BOOK   HSDB   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
OMEPRAZOLE [JAN]
Common Name English
OMEPRAZOLE COMPONENT OF ZEGERID
Common Name English
5-METHOXY-2-(((4-METHOXY-3,5,-DIMETHYL-2-PYRIDINYL)-METHYL)SULPHINYL)-1H-BENZIMIDAZOLE
Common Name English
NSC-759192
Code English
NSC-751450
Code English
1H-BENZIMIDAZOLE, 5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL)SULFINYL)-
Systematic Name English
OMEPRAZOLE COMPONENT OF YOSPRALA
Brand Name English
OMEPRAZOLE [USP-RS]
Common Name English
OMEPRAZOLE [USP MONOGRAPH]
Common Name English
OMEPRAZOLE [HSDB]
Common Name English
OMEPRAZOLE [MART.]
Common Name English
OMEPRAZOLE [USP IMPURITY]
Common Name English
LOSEC
Brand Name English
H-168/68
Code English
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole
Systematic Name English
OMEPRAZOLE [MI]
Common Name English
OMEPRAZOLE [GREEN BOOK]
Common Name English
ZEGERID COMPONENT OMEPRAZOLE
Common Name English
(RS)-6-METHOXY-2-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL) METHYLSULFINYL)-1H-BENZO(D)IMIDAZOLE
Systematic Name English
omeprazole [INN]
Common Name English
H 168/68
Code English
Omeprazole [WHO-DD]
Common Name English
OMEPRAZOLE [VANDF]
Common Name English
OMEPRAZOLE [ORANGE BOOK]
Common Name English
OMEPRAZOLE [USAN]
Common Name English
YOSPRALA COMPONENT OMEPRAZOLE
Brand Name English
Classification Tree Code System Code
WHO-ATC A02BD05
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-VATC QA02BD01
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-ATC A02BC01
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-VATC QA02BD05
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
CFR 21 CFR 520.1615
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
LIVERTOX NBK548771
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
NDF-RT N0000175525
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
FDA ORPHAN DRUG 446014
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-ATC A02BD01
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-VATC QA02BC01
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
NCI_THESAURUS C29723
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 17.1
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
NDF-RT N0000000147
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
Code System Code Type Description
MERCK INDEX
m8209
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY Merck Index
MESH
D009853
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
RXCUI
7646
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY RxNorm
NSC
751450
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
NCI_THESAURUS
C716
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
NDF-RT
N0000182140
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY Cytochrome P450 2C19 Inhibitors [MoA]
CAS
73590-58-6
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
WIKIPEDIA
OMEPRAZOLE
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
PUBCHEM
4594
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
RS_ITEM_NUM
1478505
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
USAN
X-3
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
EPA CompTox
DTXSID6021080
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
DRUG BANK
DB00338
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
FDA UNII
KG60484QX9
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
NSC
759192
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
HSDB
3575
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
EVMPD
SUB09439MIG
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
ChEMBL
CHEMBL1503
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
IUPHAR
4279
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
LACTMED
Omeprazole
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
DAILYMED
KG60484QX9
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
SMS_ID
100000092047
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
DRUG CENTRAL
1990
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
INN
5081
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
CHEBI
7772
Created by admin on Fri Dec 15 17:41:37 UTC 2023 , Edited by admin on Fri Dec 15 17:41:37 UTC 2023
PRIMARY
Related Record Type Details
MRP-2
METABOLIC ENZYME -> INHIBITOR
CYTOCHROME P450 2D6
METABOLIC ENZYME -> SUBSTRATE
Structure of OMEPRAZOLE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
POTASSIUM-TRANSPORTING ATPASE ALPHA CHAIN 1
TARGET -> INHIBITOR
CYTOCHROME P450 1A2
METABOLIC ENZYME -> INDUCER
MRP-3
TRANSPORTER -> INHIBITOR
URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B7
METABOLIC ENZYME -> INDUCER
Structure of OMEPRAZOLE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
MRP-2
TRANSPORTER -> INHIBITOR
CYTOCHROME P450 2C19
METABOLIC ENZYME -> SUBSTRATE
CYTOCHROME P450 2C19
METABOLIC ENZYME -> INHIBITOR
CYTOCHROME P450 3A4
METABOLIC ENZYME -> SUBSTRATE
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Structure of OMEPRAZOLE MAGNESIUM
SALT/SOLVATE -> PARENT
Structure of OMEPRAZOLE SODIUM
SALT/SOLVATE -> PARENT
CYTOCHROME P450 1A2 (CANINE)
METABOLIC ENZYME -> INDUCER
Structure of OMEPRAZOLE, (R)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of 2-(2-HYDROXYSULFANYL-4-METHOXY-3,5-DIMETHYL-PYRIDIN-1-IUM-1-YL)-5-METHOXY-1H-BENZIMIDAZOLE
METABOLITE ACTIVE -> PRODRUG
Structure of OMEPRAZOLE SULFONE
METABOLITE INACTIVE -> PARENT
SUBSTRATE
Structure of 3,10-DIMETHOXY-2,4-DIMETHYL-5H-BENZO(4,5)IMIDAZO(1,2-B)PYRIDO(1,2-D)(1,2,4)THIADIAZIN-13-IUM
METABOLITE ACTIVE -> PRODRUG
Structure of 5'-HYDROXYOMEPRAZOLE, R-
METABOLITE INACTIVE -> PARENT
Structure of 3-HYDROXYOMEPRAZOLE
METABOLITE INACTIVE -> PARENT
Structure of 5-O-DESMETHYLOMEPRAZOLE
METABOLITE -> PARENT
Structure of 4-METHOXY-6-(((6-METHOXY-1H-BENZIMIDAZOL-2-YL)SULFINYL)METHYL)-5-METHYL-3-PYRIDINECARBOXYLIC ACID
METABOLITE INACTIVE -> PARENT
Structure of 5-O-DESMETHYLESOMEPRAZOLE
METABOLITE INACTIVE -> PARENT
Structure of UFIPRAZOLE
METABOLITE -> PARENT
Related Record Type Details
Structure of OMEPRAZOLE PYRIDONE ACID
IMPURITY -> PARENT
Structure of OMEPRAZOLE SULFONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of H-180/29
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of UFIPRAZOLE
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of OMEPRAZOLE-N-OXIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 8-METHOXY-1,3-DIMETHYL-12-THIOXOPYRIDO(1',2':3,4)IMIDAZO(1,2-A)BENZIMIDAZOL-2(12H)-ONE
IMPURITY -> PARENT
Impurities F and G: maximum 350 ppm for the sum of the contents
EP
Structure of 9-METHOXY-1,3-DIMETHYL-12-THIOXOPYRIDO(1',2':3,4)IMIDAZO(1,2-A)BENZIMIDAZOL-2(12H)-ONE
IMPURITY -> PARENT
Impurities F and G: maximum 350 ppm for the sum of the contents
EP
Structure of N-Methyl Omeprazole
IMPURITY -> PARENT
Structure of 5-METHOXY-2-MERCAPTOBENZIMIDAZOLE
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of OMEPRAZOLE SULFONE N-OXIDE
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of DESULFOXIDE 4-DEMETHYL OMEPRAZOLE
IMPURITY -> PARENT
Structure of 4-DESMETHOXY-4-CHLOROOMEPRAZOLE
IMPURITY -> PARENT
UNSPECIFIED
EP
Related Record Type Details
Structure of 2-(2-HYDROXYSULFANYL-4-METHOXY-3,5-DIMETHYL-PYRIDIN-1-IUM-1-YL)-5-METHOXY-1H-BENZIMIDAZOLE
ACTIVE MOIETY
Structure of 3,10-DIMETHOXY-2,4-DIMETHYL-5H-BENZO(4,5)IMIDAZO(1,2-B)PYRIDO(1,2-D)(1,2,4)THIADIAZIN-13-IUM
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC Hepatic Imairment
PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966